Response to antiretroviral therapy after a single, peripartum dose of nevirapine. [electronic resource]
Producer: 20070116Description: 135-47 p. digitalISSN:- 1533-4406
- Adult
- Anti-Retroviral Agents -- administration & dosage
- Double-Blind Method
- Drug Resistance, Viral -- genetics
- Drug Therapy, Combination
- Female
- Genotype
- HIV Infections -- drug therapy
- HIV-1 -- genetics
- Humans
- Infant, Newborn
- Infectious Disease Transmission, Vertical -- prevention & control
- Kaplan-Meier Estimate
- Labor, Obstetric
- Mutation
- Nevirapine -- administration & dosage
- Pregnancy
- Pregnancy Complications, Infectious -- drug therapy
- Pregnancy Trimester, Third
- Proportional Hazards Models
- Prospective Studies
- RNA, Viral -- blood
- Risk Factors
- Treatment Failure
- Viral Load
- Zidovudine -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.